Natera Inc


Market Cap$8.55B

Compare Natera

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Natera IncNatera Inc-17.10%-64%9.50.5
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

6.3% downside

Overvalued by 6.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.55 Billion
Enterprise Value$7.98 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-4.49
Outstanding Shares120,151,688
Avg 30 Day Volume1,167,871


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-17.12
Price to Sales9.52
Price to Book Ratio12.69
Enterprise Value to Revenue8.07
Enterprise Value to EBIT-15.84
Enterprise Value to Net Income-16
Total Debt to Enterprise0.05
Debt to Equity0.46

Revenue Sources

No data

ESG Score

No data

About Natera Inc

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...